MoonLake Immunotherapeutics
MLTX
#3878
Rank
C$3.51 B
Marketcap
$55.57
Share price
2.05%
Change (1 day)
-8.10%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -C$0.15 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$77.93 Million, an increase over its 2022 earnings that were of -C$93.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.15 Billion88.5%
2023 -C$77.93 Million-16.81%
2022 -C$93.68 Million